A spokesman for Mr. Collins said the congressman had followed all ethical guidelines and said Innate was one of many companies he had been involved in. " He is very proud of the progress the company has made over the years and hopeful it will be able to develop a potentially lifesaving treatment for the millions of individuals suffering from secondary progressive multiple sclerosis," said the spokesman, Michael McAdams. In an interview this week in San Francisco, Innateâ€™s chief executive, Simon Wilkinson, seemed amused at all of the attention now being paid to what he described as his "little biotech at the wrong end of the world. 